The FDA is no longer the agency that spent years saying no
In a decision that marks a quiet but consequential turning point, the FDA has authorized fruit-flavored electronic cigarettes for adults — reversing years of its own regulatory doctrine. The move, reportedly shaped by direct pressure from President Trump on his appointed FDA Commissioner, transforms a campaign promise into enforceable policy. It raises a question that will echo through public health circles for years: when political will and regulatory science diverge, which one governs the health of a nation?
- The FDA approved mango, blueberry, and menthol vapes from Los Angeles-based Glas — the first fruit-flavored e-cigarettes ever authorized under a regulatory regime that had spent years blocking exactly these products.
- Reports emerged that President Trump personally pressured FDA Commissioner Marty Makary to approve the products, turning a campaign vow to 'save' the vaping industry into a live policy intervention.
- The decision fractures the FDA's long-standing public health posture, which treated flavored nicotine products as disproportionate risks — especially for younger users drawn in by appealing tastes.
- Competing vaping companies are almost certainly preparing applications of their own, and the industry is watching closely to see whether this approval is a one-time exception or the first crack in a much larger dam.
- Public health advocates warn that loosening flavor restrictions could expand the nicotine-using population beyond current smokers, while vaping proponents argue flavors are essential tools for adult smokers seeking to quit combustible cigarettes.
On a Tuesday in May, the FDA approved something it had spent years working to prevent: flavored vapes for adults. The agency authorized electronic cigarettes from Glas, a Los Angeles company, in mango, blueberry, and two menthol varieties — a sharp reversal from the sustained regulatory campaign the agency had waged against flavored nicotine devices.
The timing was telling. Hours before the announcement, the Wall Street Journal reported that President Trump had pressed FDA Commissioner Marty Makary to greenlight the products. Trump had made vaping a campaign issue, promising to rescue the industry from what he called overregulation. That promise has now become policy.
For years, the FDA had treated flavored vapes as a public health liability — blocking applications, denying authorizations, and maintaining that fruit and menthol flavors posed risks that outweighed any benefit as cessation tools. That posture has shifted. The approval of Glas products for adults 21 and over signals a willingness, under new political direction, to recalibrate the agency's entire approach to vaping.
Whether this is an isolated decision or the opening move in a broader loosening remains unclear. But other companies are watching. If Glas's approval holds, applications from competitors will almost certainly follow — and the FDA will face pressure to extend its new permissiveness to pods, disposables, and vape liquids long kept off-limits.
The public health stakes are genuinely contested. Vaping advocates argue flavored products help adult smokers move away from combustible cigarettes. Critics fear that accessible, appealing flavors will draw in new users and undermine age restrictions. Both concerns rest on real mechanisms. What has changed is not the science — it is who is deciding how much the risks matter.
On a Tuesday in May, the Food and Drug Administration did something it had spent years working against: it approved flavored vapes for adults. The agency authorized electronic cigarettes from Glas, a Los Angeles company, in mango, blueberry, and two menthol varieties—all products designed to appeal through taste. For anyone who had watched the FDA wage a sustained campaign against flavored nicotine devices, the decision landed as a sharp reversal.
The timing was not coincidental. Hours before the announcement, the Wall Street Journal reported that President Donald Trump had pressed FDA Commissioner Marty Makary to greenlight these products. Trump had made vaping a campaign issue, promising to "save" the industry from what he characterized as overregulation. Now, with him back in office, that promise was materializing into policy.
The context matters. For years, the FDA had moved methodically to restrict flavored vapes, treating them as a public health concern—particularly around youth access and addiction potential. Menthol and fruit flavors were seen as especially attractive to younger users. The agency had blocked countless applications, denied emergency authorizations, and maintained that flavored e-cigarettes posed risks that outweighed any potential benefit as smoking cessation tools. It was a consistent regulatory posture, grounded in epidemiological concern.
That posture has now shifted. The approval of Glas products for adults 21 and over signals something larger: a willingness to recalibrate how the FDA thinks about vaping regulation under the current administration. Whether this is an isolated decision or the opening move in a broader loosening of restrictions remains unclear. The agency has not yet announced a wholesale change in policy. But the signal is unmistakable.
What happens next will depend partly on how the FDA interprets its own authority and partly on what political pressure continues to mount. Other vaping companies are almost certainly watching. If Glas's approval stands and faces no legal challenge, applications from competitors will likely follow. The question then becomes whether the FDA will approve them too, and whether the agency will eventually relax restrictions on other flavored nicotine products—vape liquids, pods, disposables—that have been off-limits.
The public health implications are genuinely uncertain. Proponents of vaping argue that flavored products help adult smokers transition away from combustible cigarettes. Critics worry that easier access to appealing flavors will expand the overall nicotine-using population and potentially draw in younger users despite age restrictions. Neither side is wrong about the underlying mechanism; they simply weigh the risks and benefits differently.
What is clear is that regulatory philosophy has changed. The FDA, under new leadership and new political direction, is no longer the agency that spent the last several years saying no to flavored vapes. It is now an agency that says yes. How far that yes extends, and what it means for the millions of Americans who use or might use these products, will unfold over the coming months.
Citações Notáveis
Trump had made vaping a campaign issue, promising to 'save' the industry from what he characterized as overregulation— Trump administration policy position
A Conversa do Hearth Outra perspectiva sobre a história
Why does the flavor matter so much? It's just taste.
Flavor is how a product becomes desirable. Menthol and fruit don't just taste good—they mask the harshness of nicotine, they make the experience smoother, they signal something fun rather than medicinal. That's why the FDA restricted them in the first place.
So this is really about marketing, not health?
It's both. The health question is real: do flavors help adults quit smoking, or do they create new nicotine users? The marketing question is real too: flavors sell products. The FDA had decided the marketing risk outweighed the cessation benefit. Now it's decided the opposite.
What changed? Did the science change?
The science didn't change. What changed is who's in charge and what they prioritize. Trump promised to deregulate vaping. He's keeping that promise. The FDA is following.
Will other companies get approved now?
Almost certainly. If Glas gets approved and nothing bad happens immediately, why would the FDA say no to the next applicant? You're looking at the first domino.
What about younger people? The age restriction is 21.
Age restrictions exist on paper. Enforcement is another matter. If flavored vapes are easier to get, some will reach people under 21. Whether that's a big problem or a small one depends on how you measure it.
So this is a gamble?
Every regulatory decision is a gamble. The FDA gambled for years that restricting flavors would protect public health. Now it's gambling that allowing them won't. We won't know who was right for a while.